A simple and selective method for introducing stable 13C and 15N isotopes into the structure of the sodium salt of 4-oxo-1,4-dihydropyrazolo[5,1-c][1,2,4]triazine-3,8-dicarboxylic acid diethyl ester, a potential antiglycation agent, has been developed. Labeled [1,3-13C2]-malonic ester (99% 13C) was used as the 13C isotope donor. The introduction of the 15N atom was carried out using enriched sodium nitrite (98% 15N). The obtained 13C2 and 15N isotope-labeled analog of a promising antidiabetic compound of the pyrazolo- [5,1-c][1,2,4]triazine series was characterized by NMR spectroscopy and high-resolution mass spectrometry.
Similar content being viewed by others
References
Rusinov, V. L.; Ulomskii, Е. N.; Chupakhin, O. N.; Charushin, V. N. Russ. Chem. Bull., Int. Ed. 2008, 57, 985. [Izv. Akad. Nauk, Ser. Khim.2008, 967.]
Rusinov, V. L.; Charushin, V. N.; Chupakhin, O. N. Russ. Chem. Bull., Int. Ed. 2018, 67, 573. [Izv. Akad. Nauk, Ser. Khim.2018, 573.]
Karpenko, I.; Deev, S.; Kiselev, O.; Charushin, V.; Rusinov, V.; Ulomsky, E.; Deeva, E.; Yanvarev, D.; Ivanov, A.; Smirnova, O.; Kochetkov, S.; Chupakhin, O.; Kukhanova, M. Antimicrob. Agents Chemother. 2010, 54, 2017.
Chupakhin, O. N.; Charushin, V. N.; Rusinov, V. L. Herald Russ. Acad. Sci.2016, 86, 206. [Vestn. RAN2016, 86, 546.]
Kiselev, O. I.; Deeva, Е. G.; Melnikova, T. I.; Kozeletskaya, K. N.; Kiselev, А. S.; Rusinov, V. L.; Charushin, V. N.; Chupakhin, О. N. Voprosy Virusologii2012, 57, 9.
Guerrini, G.; Ciciani, G.; Daniele, S.; Martini, C.; Costagli, C.; Guarino, C.; Selleri, S. Bioorg. Med. Chem.2018, 26, 2475.
Li, M.; Zhao, B.-X. Eur. J. Med. Chem. 2014, 85, 311.
Rusinov, V. L.; Sapozhnikova, I. M.; Bliznik, A. M.; Chupakhin, O. N.; Charushin, V. N.; Spasov, A. A.; Vassiliev, P. M.; Kuznetsova, V. A.; Rashchenko, A. I.; Babkov, D. A. Arch. Pharm. Chem. Life Sci. 2017, 350, e1600361.
Thornalley, P. J. Arch. Biochem. Biophys. 2003, 419, 31. 10. Ramasamy, R.; Yan, S. F.; Schmidt, A. M. Ann. N. Y. Acad. Sci. 2011, 1243, 88.
Goh, S.-Y.; Coope, M. E. J. Clin. Endocrinol. Metab.2008, 93, 1143.
Knebel, N. G.; Sharp, S. R.; Madigan, M. J. J. Mass Spectrom. 1995, 30, 1149.
Khojasteh, S. C.; Yue, Q.; Ma, S.; Castanedo, G.; Chen, J. Z.; Lyssikatos, J.; Mulder, T.; Takahashi, R.; Ly, J.; Messick, K.; Jia, W.; Liu, L.; Hop, C. E. C. A.; Wong, H. Drug Metab. Dispos. 2014, 42, 343.
Nakagawa, A.; Nakamura, K.; Maeda, K.; Kamataki, T.; Kato, R. Life Sci.1987, 41, 133.
Hesk, D.; McNamara, P. J. Labelled Compd. Radiopharm. 2007, 50, 875.
Artemov, D.; Bhujwalla, Z. M.; Maxwell, R. J.; Griffiths, J. R.; Judson, I. R.; Leach, M. O.; Glickson, J. D. Magn. Reson. Med.1995, 34, 338.
Spinelli, D.; Zanirato, P.; Miceli, E. D.; Lamartina, L.; Guerrera, F. J. Org. Chem.1997, 62, 4921.
Deev, S. L.; Shenkarev, Z. O.; Shestakova, T. S.; Chupakin, O. N.; Rusinov, V. L.; Arseniev, A. S. J. Org. Chem.2010, 75, 8487.
van Linden, O. P. J.; Wijtmans, M.; Roumen, L.; Rotteveel, L.; Leurs, R.; de Esch, I. J. P. J. Org. Chem.2012, 77, 7355.
Deev, S. L.; Paramonov, A. S.; Shestakova, T. S.; Khalymbadzha, I. A.; Chupakhin, O. N.; Subbotina, J. O.; Eltsov, O. S.; Slepukhin, P. A.; Rusinov, V. L.; Arseniev, A. S.; Shenkarev, Z. O. Beilstein J. Org. Chem.2017, 13, 2535.
Khalymbadzha, I. A.; Shestakova, T. S.; Deev, S. L.; Rusinov, V. L.; Chupakhin, O. N.; Shenkarev, Z. O.; Arseniev, A. S. Russ. Chem. Bull., Int. Ed. 2013, 62, 521. [Izv. Akad. Nauk, Ser. Khim.2013, 519.]
Ryabokon', I. G.; Kalinin, V. N.; Polumbrik, O. M.; Markovskii, L. N. Chem. Heterocycl. Compd.1985, 21, 1175. [Khim. Geterotsikl. Soedin.1985, 1425.]
Lyčka, A.; Fryšova, I.; Slouka, J. Magn. Reson. Chem. 2007, 45, 46.
Farras, J.; Fos, E.; Ramos, R.; Vilarrasa, J. J. Org. Chem.1988, 53, 887.
Chatzopoulou, M.; Martínez, R. F.; Willis, N. J.; Claridge, T. D. W.; Wilson, F. X.; Wynne, G. M.; Davies, S. G.; Russell, A. J. Tetrahedron2018, 74, 5280.
Shestakova, T. S.; Deev, S. L.; Ulomskii, E. N.; Rusinov, V. L.; Kodess, M. I.; Chupakhin, O. N. ARKIVOC2009, (ix), 69.
Kumar, A. A. K.; Bodke, Y. D.; Lakra, P. S.; Sambasivam, G.; Bhat, K. G. Med. Chem. Res.2017, 26, 714.
This work was carried out as part of the state assignment of the Ministry of Higher Education and Science of the Russian Federation (4.6351.2017/8.9) and with the financial support of the Russian Foundation for Basic Research (grant 17-03-01029)
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information file containing 1H and 13C NMR spectra of compound [13C2,15N]-1 is available at the journal website at http://link.springer.com/journal/10593.
Translated from Khimiya Geterotsiklicheskikh Soedinenii, 2019, 55(9), 856–860
Electronic supplementary material
ESM 1
(PDF 1475 kb)
Rights and permissions
About this article
Cite this article
Shestakova, T.S., Eltsov, O.S., Yakovleva, Y.А. et al. Stable Isotope-Labeled Azoloazines. Synthesis of a 13С and 15N Isotope-Enriched Derivative of Pyrazolo[5,1-c][1,2,4]Triazine –Potential Antidiabetic Agent. Chem Heterocycl Comp 55, 856–860 (2019). https://doi.org/10.1007/s10593-019-02549-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-019-02549-8